{"insightID":"a2a5cf7c-2947-4160-8c6e-340ec9e893ce","pixelReturn":[{"pixelExpression":"CachedPanel ( 0 ) ;","isMeta":false,"output":{"panelId":"0","panelLabel":"Most Common Diseases in the US","view":"visualization","viewOptions":"{\"type\":\"standard\"}","viewOptionsMap":{"federate-view":{"app_id":"98e8057b-f05d-44db-9d29-39b50d3cf75f"},"visualization":{"type":"standard"}},"config":{},"ornaments":{},"events":{"onSingleClick":{"Unfilter":[{"disabledVisuals":["Grid","Sunburst"],"default":true,"query":"UnfilterFrame(<SelectedColumn>);","options":{},"refresh":false,"disabled":false,"panel":""}]},"onBrush":{"Filter":[{"default":true,"query":"if(IsEmpty(<SelectedValues>), UnfilterFrame(<SelectedColumn>), SetFrameFilter(<SelectedColumn>==<SelectedValues>));","options":{},"refresh":false,"disabled":false,"panel":""}]}},"comments":{},"position":{},"filters":[],"order":[],"cbv":[]},"operationType":["CACHED_PANEL"]},{"pixelExpression":"Select ( Disease , Location_1 , Recruitment , Study_Results , Title ) .as ( [ Disease , Location_1 , Recruitment , Study_Results , Title ] ) | With ( Panel ( 0 ) ) | Format ( type = [ 'table' ] ) | TaskOptions ( { \"0\" : { \"layout\" : \"Cluster\" , \"alignment\" : { \"cluster\" : [ \"Disease\" ] , \"label\" : [ \"Disease\" ] , \"tooltip\" : [ \"Location_1\" , \"Recruitment\" , \"Study_Results\" , \"Title\" ] } } } ) | Collect ( 500 ) ;","isMeta":false,"output":{"data":{"values":[["ABNORMAL_FINDINGS_ON_RADIOLOGICAL_EXAMINATION_OF_BREAST","Michigan","Recruiting","No_Results_Available","Breast_Lesion_Analysis_for_Tomosynthesis_Mammography"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Illinois","Completed","No_Results_Available","3-AP_and_High-Dose_Cytarabine_in_Treating_Patients_With_Advanced_Hematologic_Malignancies"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Washington","Completed","No_Results_Available","Infusion_of_Off-the-Shelf_Expanded_Cord_Blood_Cells_to_Augment_Cord_Blood_Transplant_in_Patients_With_Hematologic_Malignancies"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Texas","Terminated","No_Results_Available","Sunitinib_in_Treating_Patients_With_Idiopathic_Myelofibrosis"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","California","Completed","No_Results_Available","Dasatinib_in_Treating_Young_Patients_With_Recurrent_or_Refractory_Solid_Tumors_or_Philadelphia_Chromosome-Positive_Acute_Lymphoblastic_Leukemia_or_Chronic_Myelogenous_Leukemia_That_Did_Not_Respond_to_Imatinib_Mesylate"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Alabama","Completed","No_Results_Available","Etanercept_in_Treating_Young_Patients_With_Idiopathic_Pneumonia_Syndrome_After_Undergoing_a_Donor_Stem_Cell_Transplant"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Maryland","Completed","No_Results_Available","3-AP_and_Fludarabine_in_Treating_Patients_With_Myeloproliferative_Disorders,_Chronic_Myelomonocytic_Leukemia,_or_Accelerated_Phase_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Maryland","Completed","No_Results_Available","7-Hydroxystaurosporine_and_Perifosine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_Chronic_Myelogenous_Leukemia_or_High_Risk_Myelodysplastic_Syndromes"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Texas","Completed","No_Results_Available","Vaccine_Therapy_Plus_Immune_Adjuvant_in_Treating_Patients_With_Chronic_Myeloid_Leukemia,_Acute_Myeloid_Leukemia,_or_Myelodysplastic_Syndrome"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Washington","Completed","No_Results_Available","Fludarabine_Phosphate,_Busulfan,_and_Anti-Thymocyte_Globulin_Followed_By_Donor_Peripheral_Blood_Stem_Cell_Transplant,_Tacrolimus,_and_Methotrexate_in_Treating_Patients_With_Myeloid_Malignancies"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Colorado","Terminated","No_Results_Available","Dasatinib_and_Cyclosporine_in_Treating_Patients_With_Chronic_Myelogenous_Leukemia_Refractory_or_Intolerant_to_Imatinib_Mesylate"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","California","Active,_not_recruiting","No_Results_Available","Fludarabine_Phosphate,_Low-Dose_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies_or_Kidney_Cancer"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Colorado","Completed","No_Results_Available","Treosulfan,_Fludarabine_Phosphate,_and_Total-Body_Irradiation_Before_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia,_Myelodysplastic_Syndrome,_Acute_Lymphoblastic_Leukemia"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Washington","Terminated","No_Results_Available","Therapeutic_Allogeneic_Lymphocytes_and_Aldesleukin_in_Treating_Patients_With_High-Risk_or_Recurrent_Myeloid_Leukemia_After_Undergoing_Donor_Stem_Cell_Transplant"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","California","Completed","No_Results_Available","Nilotinib_and_Imatinib_Mesylate_After_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_ALL_or_CML"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Maryland","Completed","No_Results_Available","Chemotherapy_Plus_Sargramostim_in_Treating_Patients_With_Refractory_Myeloid_Cancer"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","California","Terminated","No_Results_Available","Temsirolimus_and_Imatinib_Mesylate_in_Treating_Patients_With_Chronic_Myelogenous_Leukemia"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA","Texas","Completed","No_Results_Available","Imatinib_Mesylate_and_Decitabine_in_Treating_Patients_With_Chronic_Myelogenous_Leukemia"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","Washington","Active,_not_recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_in_Preventing_GVHD_in_Children"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","California","Active,_not_recruiting","No_Results_Available","Vaccine_Therapy_in_Reducing_the_Frequency_of_Cytomegalovirus_Events_in_Patients_With_Hematologic_Malignancies_Undergoing_Donor_Stem_Cell_Transplant"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","Pennsylvania","Recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_From_HLA-Matched_Related_and_Unrelated_Donors_in_Preventing_GVHD"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","California","757","Not_yet_recruiting","Multi-peptide_CMV-Modified_Vaccinia_Ankara_Vaccine_in_Reducing_CMV_Related_Complications_in_Patients_With_Blood_Cancer_Undergoing_Donor_Stem_Cell_Transplant"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","California","Active,_not_recruiting","No_Results_Available","Multi-antigen_CMV-MVA_Triplex_Vaccine_in_Reducing_CMV_Complications_in_Patients_Previously_Infected_With_CMV_and_Undergoing_Donor_Hematopoietic_Cell_Transplant"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","New_York","Recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Blood_Cancer"],["ACCELERATED_PHASE_CHRONIC_MYELOGENOUS_LEUKEMIA,_BCR-ABL1_POSITIVE","New_Mexico","Recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Blood_Cancer"],["ACCELERATED_PHASE_OF_DISEASE","Illinois","Active,_not_recruiting","No_Results_Available","Veliparib_and_Temozolomide_in_Treating_Patients_With_Acute_Leukemia"],["ACCELERATED_PHASE_OF_DISEASE","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Chronic_Myeloid_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Undifferentiated_Myeloproliferative_Disorders"],["ACCELERATED_PHASE_OF_DISEASE","California","Active,_not_recruiting","No_Results_Available","Fludarabine_Phosphate,_Low-Dose_Total-Body_Irradiation,_and_Peripheral_Blood_Stem_Cell_Transplant_Followed_by_Donor_Lymphocyte_Infusion_in_Treating_Older_Patients_With_Chronic_Myeloid_Leukemia"],["ACCELERATED_PHASE_OF_DISEASE","Illinois","Completed","No_Results_Available","Belinostat_and_Azacitidine_in_Treating_Patients_With_Advanced_Hematologic_Cancers_or_Other_Diseases"],["ACINAR_CELL_ADENOCARCINOMA_OF_THE_PANCREAS","Illinois","Active,_not_recruiting","No_Results_Available","Genotype-guided_Dosing_of_mFOLFIRINOX_Chemotherapy_in_Patients_With_Previously_Untreated_Advanced_Gastrointestinal_Malignancies"],["ACINAR_CELL_ADENOCARCINOMA_OF_THE_PANCREAS","California","Withdrawn","No_Results_Available","Dynamic_Contrast_Enhanced_MRI_in_Patients_With_Advanced_Breast_or_Pancreatic_Cancer_With_Metastases_to_the_Liver_or_Lung"],["ACQUIRED_IMMUNE_DEFICIENCY_SYNDROME_VIRUS","Kentucky","Recruiting","No_Results_Available","Brief_Intervention_for_Rural_Women_at_High_Risk_for_HIV-HCV"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Florida","Completed","No_Results_Available","DVD-based_HIV-HCV_Prevention_Intervention_for_Drug-Involved_Latino_Criminal_Justice_Clients"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","California","Completed","No_Results_Available","Treatment_of_Depression_With_Massage_in_HIV"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","California","Completed","No_Results_Available","Effectiveness_of_Structured_Ecosystems_Therapy_for_Reducing_HIV_Risk_Behaviors_and_Improving_Treatment_Adherence_in_HIV_Infected_Men_Released_From_Prison"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Safety_and_Survival_of_Genetically_Modified_White_Blood_Cells_in_HIV-Infected_Persons_-_A_Study_in_Identical_Twin_Pairs"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Fluconazole_Prophylaxis_of_Thrush_in_AIDS"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Voriconazole_vs._Amphotericin_B_in_the_Treatment_of_Invasive_Aspergillosis"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Once-Daily_Drug_Regimen_for_HIV-Infected_Patients"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Genetically_Modified_Lymphocytes_to_Treat_HIV-Infected_Identical_Twins_-_Study_Modifications"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Pennsylvania","Completed","No_Results_Available","The_Use_of_Reiki_for_Patients_With_Advanced_AIDS"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Twins_Study_of_Gene_Therapy_for_HIV_Infection"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Thalidomide_to_Treat_Oral_Lesions_in_HIV-Infected_Patients"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Kansas","Completed","No_Results_Available","Effectiveness_of_Enhanced_Counseling_and_Observed_Therapy_on_Antiretroviral_Adherence_in_People_With_HIV"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","New_Mexico","Completed","No_Results_Available","HIV_Prevention_Intervention_for_Couples"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","California","Completed","No_Results_Available","Medications_for_Chronic_HIV:_Education_and_Collaboration"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","White_Blood_Cell_Infusions_to_Treat_HIV_Infection"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Subcutaneously_Administered_Interleukin-12_Therapy_in_HIV-Infected_Patients_With_Disseminated_Mycobacterium_Avium_Complex_Infection"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","California","Terminated","No_Results_Available","Computer-Assisted_Adherence_Program_for_Patients_Taking_Anti-HIV_Drugs"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Home_Treatment_of_HIV-Infected_Patients_With_Interleukin-2_With_or_Without_a_Tumor_Necrosis_Factor_Antagonist"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","California","Completed","No_Results_Available","Immune_Restoration_by_Lipoic_Acid_in_AIDS"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","A_Randomized_Pilot_Study_for_the_Treatment_of_AIDS_or_AIDS_Related_Complex_With_an_Alternating_or_Simultaneous_Combination_Regimen_of_AZT_and_2,3-Dideoxyinosine"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Phase_I_Study_of_APL_400-003,_a_Candidate_HIV_Vaccine,_in_HIV-Negative_Volunteers"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Phase_I_Protocol_for_the_Evaluation_of_the_Safety_and_Immunogenicity_of_Vaccination_With_Synthetic_HIV_Envelope_Peptides_in_Patients_With_Early_Human_Immunodeficiency_Virus_Infection"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","Interleukin-2_Therapy_for_HIV_Infection_-_Supplemental_Procedures"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROME","Maryland","Completed","No_Results_Available","A_Phase_I_-II_Study_of_the_Protease_Inhibitor_Indinavir_(MK-0639)_in_Children_With_HIV_Infection"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROMES","Maryland","Recruiting","No_Results_Available","CD34+_(Non-Malignant)_Stem_Cell_Selection_for_Patients_Receiving_Allogeneic_Stem_Cell_Transplantation"],["ACQUIRED_IMMUNODEFICIENCY_SYNDROMES","New_Mexico","Recruiting","No_Results_Available","CD34+_(Non-Malignant)_Stem_Cell_Selection_for_Patients_Receiving_Allogeneic_Stem_Cell_Transplantation"],["ACTIVATING_RAS_MUTATION","Arizona","Recruiting","No_Results_Available","Trametinib_in_Treating_Patients_With_Relapsed_or_Refractory_Juvenile_Myelomonocytic_Leukemia"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Washington","Recruiting","No_Results_Available","Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","California","Recruiting","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_With_or_Without_Ex-vivo_Expanded_Cord_Blood_Progenitor_Cells_in_Treating_Patients_With_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Colorado","Recruiting","No_Results_Available","Umbilical_Cord_Blood_Transplant,_Cyclophosphamide,_Fludarabine_Phosphate,_and_Total-Body_Irradiation_in_Treating_Patients_With_Hematologic_Disease"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Tac,_Mini-MTX,_MMF_Versus_Tac,_MTX_for_GVHD_Prevention"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","California","Active,_not_recruiting","No_Results_Available","Liposomal_Cytarabine-Daunorubicin_CPX-351_in_Treating_Patients_With_Untreated_Myelodysplastic_Syndrome_or_Acute_Myeloid_Leukemia"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Pennsylvania","Recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_From_HLA-Matched_Related_and_Unrelated_Donors_in_Preventing_GVHD"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Washington","Active,_not_recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_in_Preventing_GVHD_in_Children"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Washington","Recruiting","No_Results_Available","Filgrastim,_Cladribine,_Cytarabine,_and_Mitoxantrone_With_Sorafenib_Tosylate_in_Treating_Patients_With_Newly-Diagnosed,_Acute_Myeloid_Leukemia_or_High-Risk_Myelodysplastic_Syndrome"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","New_Mexico","Not_yet_recruiting","No_Results_Available","Infusion_of_Expanded_Cord_Blood_Cells_in_Addition_to_Single_Cord_Blood_Transplant_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myeloid_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Colorado","Recruiting","No_Results_Available","Treosulfan,_Fludarabine_Phosphate,_and_Total-Body_Irradiation_in_Treating_Patients_With_Hematological_Cancer_Who_Are_Undergoing_Umbilical_Cord_Blood_Transplant"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","New_York","Not_yet_recruiting","No_Results_Available","Infusion_of_Expanded_Cord_Blood_Cells_in_Addition_to_Single_Cord_Blood_Transplant_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myeloid_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Washington","Active,_not_recruiting","No_Results_Available","Filgrastim,_Cladribine,_Cytarabine,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_Newly_Diagnosed_or_Relapsed-Refractory_Acute_Myeloid_Leukemia_or_High-Risk_Myelodysplastic_Syndromes"],["ACUTE_BIPHENOTYPIC_LEUKEMIA","Washington","Enrolling_by_invitation","No_Results_Available","Management_of_Platelet_Transfusion_Therapy_in_Patients_With_Blood_Cancer_or_Treatment-Induced_Thrombocytopenia"],["ACUTE_ERYTHROID_LEUKEMIA","California","Recruiting","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_With_or_Without_Ex-vivo_Expanded_Cord_Blood_Progenitor_Cells_in_Treating_Patients_With_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_ERYTHROID_LEUKEMIA","Illinois","Active,_not_recruiting","No_Results_Available","Vorinostat_and_Azacitidine_in_Treating_Patients_With_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ACUTE_ERYTHROID_LEUKEMIA_IN_REMISSION","Washington","Recruiting","No_Results_Available","Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ACUTE_LEUKEMIA","California","Recruiting","No_Results_Available","High_Dose_Cyclophosphamide,_Tacrolimus,_and_Mycophenolate_Mofetil_in_Preventing_Graft_Versus_Host_Disease_in_Patients_With_Hematological_Malignancies_Undergoing_Myeloablative_or_Reduced_Intensity_Donor_Stem_Cell_Transplant"],["ACUTE_LEUKEMIAS_OF_AMBIGUOUS_LINEAGE","Alabama","Terminated","No_Results_Available","Obatoclax_Mesylate,_Vincristine_Sulfate,_Doxorubicin_Hydrochloride,_and_Dexrazoxane_Hydrochloride_in_Treating_Young_Patients_With_Relapsed_or_Refractory_Solid_Tumors,_Lymphoma,_or_Leukemia"],["ACUTE_LEUKEMIA_IN_REMISSION","Washington","Recruiting","No_Results_Available","Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ACUTE_LEUKEMIA_IN_REMISSION","New_York","Recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Blood_Cancer"],["ACUTE_LEUKEMIA_IN_REMISSION","New_Mexico","Recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Blood_Cancer"],["ACUTE_LEUKEMIA_OF_AMBIGUOUS_LINEAGE","Georgia","Active,_not_recruiting","No_Results_Available","Laboratory-Treated_Donor_Cord_Blood_Cell_Infusion_Following_Combination_Chemotherapy_in_Treating_Younger_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ACUTE_LEUKEMIA_OF_AMBIGUOUS_LINEAGE","Pennsylvania","Recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_From_HLA-Matched_Related_and_Unrelated_Donors_in_Preventing_GVHD"],["ACUTE_LEUKEMIA_OF_AMBIGUOUS_LINEAGE","Washington","Recruiting","No_Results_Available","High_Throughput_Drug_Sensitivity_Assay_and_Genomics-_Guided_Treatment_of_Patients_With_Relapsed_or_Refractory_Acute_Leukemia"],["ACUTE_LEUKEMIA_OF_AMBIGUOUS_LINEAGE","Washington","Active,_not_recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_in_Preventing_GVHD_in_Children"],["ACUTE_LEUKEMIA_OF_AMBIGUOUS_LINEAGE","Washington","Recruiting","No_Results_Available","Higher_or_Lower_Dose_Cladribine,_Cytarabine,_and_Mitoxantrone_in_Treating_Medically_Less_Fit_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia_or_Myeloid_Neoplasm"],["ACUTE_LIVER_FAILURE","Michigan","Completed","No_Results_Available","Prevention_of_Recurrent_Hepatitis_B_After_Liver_Transplantation"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","New_York","Recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Blood_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Tac,_Mini-MTX,_MMF_Versus_Tac,_MTX_for_GVHD_Prevention"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Utah","Active,_not_recruiting","No_Results_Available","Pentostatin_and_Lymphocyte_Infusion_in_Preventing_Graft_Rejection_in_Patients_Who_Have_Undergone_Donor_Stem_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Methods_to_Enhance_the_Safety_and_Effectiveness_of_Stem_Cell_Transplants"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Washington","Active,_not_recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total-Body_Irradiation,_and_Donor_Bone_Marrow_Transplant_Followed_by_Donor_Natural_Killer_Cell_Therapy,_Mycophenolate_Mofetil,_and_Tacrolimus_in_Treating_Patients_With_Hematologic_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","New_Mexico","Not_yet_recruiting","No_Results_Available","Irradiated_Donor_Cells_Following_Stem_Cell_Transplant_in_Controlling_Cancer_in_Patients_With_Hematologic_Malignancies"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Illinois","Active,_not_recruiting","No_Results_Available","Veliparib_and_Temozolomide_in_Treating_Patients_With_Acute_Leukemia"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Colorado","Recruiting","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_in_Treating_Patients_With_Hematologic_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Colorado","Completed","No_Results_Available","Graft-Versus-Host_Disease_Prophylaxis_in_Treating_Patients_With_Hematologic_Malignancies_Undergoing_Unrelated_Donor_Peripheral_Blood_Stem_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","California","Recruiting","No_Results_Available","Ibrutinib_in_Preventing_Acute_Leukemia_in_Patients_After_Reduced-Intensity_Conditioning_and_Stem_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Improving_Blood_Stem_Cell_Collection_and_Transplant_Procedures"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Washington","Recruiting","No_Results_Available","Comparison_of_Triple_GVHD_Prophylaxis_Regimens_for_Nonmyeloablative_or_Reduced_Intensity_Conditioning_Unrelated_Mobilized_Blood_Cell_Transplantation"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Minnesota","Recruiting","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_in_Treating_Patients_With_Hematologic_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Minnesota","Terminated","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_in_Treating_Patients_With_Hematologic_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Intra-Osseous_Co-Transplant_of_UCB_and_hMSC"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Maryland","Terminated","No_Results_Available","Phase_I-II_Trial_of_Early_Infusion_of_Rapidly-generated_Multivirus_Specific_T_Cells_(MVST)_to_Prevent_Post_Transplant_Viral_Infections"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","New_Mexico","Recruiting","No_Results_Available","Fludarabine_Phosphate,_Cyclophosphamide,_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Blood_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Washington","Enrolling_by_invitation","No_Results_Available","Management_of_Platelet_Transfusion_Therapy_in_Patients_With_Blood_Cancer_or_Treatment-Induced_Thrombocytopenia"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","Colorado","Terminated","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_in_Treating_Patients_With_Hematologic_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA","New_York","Not_yet_recruiting","No_Results_Available","Irradiated_Donor_Cells_Following_Stem_Cell_Transplant_in_Controlling_Cancer_in_Patients_With_Hematologic_Malignancies"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_(ALL)","Maryland","Active,_not_recruiting","No_Results_Available","Ultra-Low_Dose_IL-2_Therapy_as_GVHD_Prophylaxis_in_Haploidentical_Allogeneic_Stem_Cell_Transplantation"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_(ALL)","New_Mexico","Recruiting","No_Results_Available","CD34+_(Malignant)_Stem_Cell_Selection_for_Patients_Receiving_Allogenic_Stem_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_(ALL)","New_York","Recruiting","No_Results_Available","CD34+_(Malignant)_Stem_Cell_Selection_for_Patients_Receiving_Allogenic_Stem_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","Active,_not_recruiting","No_Results_Available","Multi-antigen_CMV-MVA_Triplex_Vaccine_in_Reducing_CMV_Complications_in_Patients_Previously_Infected_With_CMV_and_Undergoing_Donor_Hematopoietic_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","Recruiting","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_With_or_Without_Ex-vivo_Expanded_Cord_Blood_Progenitor_Cells_in_Treating_Patients_With_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","New_York","Not_yet_recruiting","No_Results_Available","Infusion_of_Expanded_Cord_Blood_Cells_in_Addition_to_Single_Cord_Blood_Transplant_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myeloid_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","757","Not_yet_recruiting","Multi-peptide_CMV-Modified_Vaccinia_Ankara_Vaccine_in_Reducing_CMV_Related_Complications_in_Patients_With_Blood_Cancer_Undergoing_Donor_Stem_Cell_Transplant"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Oregon","Completed","No_Results_Available","Total-Body_Irradiation_With_or_Without_Fludarabine_Phosphate_Followed_By_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Cancer"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","New_Mexico","Not_yet_recruiting","No_Results_Available","Infusion_of_Expanded_Cord_Blood_Cells_in_Addition_to_Single_Cord_Blood_Transplant_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myeloid_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Washington","Recruiting","No_Results_Available","211^At-BC8-B10_Before_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Myelodysplastic_Syndrome"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Targeted_Marrow_Irradiation,_Fludarabine_Phosphate,_and_Busulfan_Before_Donor_Progenitor_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Experimental_Bone_Marrow_Transplant_Protocol"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","Texas","Completed","No_Results_Available","Belinostat_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndrome"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","California","Completed","No_Results_Available","Haploidentical_Transplantation_in_Patients_With_Acute_Leukemia_and_Myelodysplasia"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Stem_Cell_Transplantation_for_Patients_With_Cancers_of_the_Blood"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","Texas","548","Recruiting","Study_of_Inotuzumab_Ozogamicin_in_Patients_With_B-cell_Lineage_Acute_Lymphocytic_Leukemia_With_Positive_Minimal_Residual_Disease"],["ACUTE_LYMPHOCYTIC_LEUKEMIA","District_of_Columbia","Active,_not_recruiting","No_Results_Available","Pilot_Study_of_Lupron_to_Improve_Immune_Function_After_Allogeneic_Bone_Marrow_Transplantation"],["ACUTE_LYMPHOID_LEUKEMIA","Indiana","Active,_not_recruiting","No_Results_Available","Multicenter_Phase_II_of_CD26_Using_Sitagliptin_for_Engraftment_After_UBC_Transplant"],["ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Florida","Active,_not_recruiting","No_Results_Available","Alisertib_in_Treating_Patients_With_Myelofibrosis_or_Relapsed_or_Refractory_Acute_Megakaryoblastic_Leukemia"],["ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","California","Recruiting","No_Results_Available","Donor_Umbilical_Cord_Blood_Transplant_With_or_Without_Ex-vivo_Expanded_Cord_Blood_Progenitor_Cells_in_Treating_Patients_With_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Myelodysplastic_Syndromes"],["ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Washington","Recruiting","No_Results_Available","Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Illinois","Active,_not_recruiting","No_Results_Available","Vorinostat_and_Azacitidine_in_Treating_Patients_With_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ACUTE_MYELOCYTIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Experimental_Bone_Marrow_Transplant_Protocol"],["ACUTE_MYELOGENOUS_LEUKEMIA","Arizona","Active,_not_recruiting","No_Results_Available","Selecting_a_Favorable_KIR_Donor_in_Unrelated_HCT_for_AML"],["ACUTE_MYELOGENOUS_LEUKEMIA","New_York","Active,_not_recruiting","No_Results_Available","Posaconazole_Versus_Micafungin_for_Prophylaxis_Against_Invasive_Fungal_Infections_During_Neutropenia_in_Patients_Undergoing_Chemotherapy_for_Acute_Myelogenous_Leukemia,_Acute_Lymphocytic_Leukemia_or_Myelodysplastic_Syndrome"],["ACUTE_MYELOGENOUS_LEUKEMIA","Texas","Completed","No_Results_Available","Granulocyte-colony_Stimulating_Factor_(G-CSF)_and_Plerixafor_Plus_Sorafenib_for_Acute_Myelogenous_Leukemia_(AML)_With_FLT3_Mutations"],["ACUTE_MYELOGENOUS_LEUKEMIA","Massachusetts","Active,_not_recruiting","No_Results_Available","Blockade_of_PD-1_in_Conjunction_With_the_Dendritic_Cell-AML_Vaccine_Following_Chemotherapy_Induced_Remission"],["ACUTE_MYELOGENOUS_LEUKEMIA","Texas","Withdrawn","No_Results_Available","Therapy_of_Relapsed_AML_With_Chemotherapy_and_Dendritic_Cell_Activated_Lymphocytes"],["ACUTE_MYELOGENOUS_LEUKEMIA","Kentucky","Completed","No_Results_Available","Phase_I_Using_Velcade_&_Idarubicin_in_Elderly_and_Relapsed_AML"],["ACUTE_MYELOGENOUS_LEUKEMIA","New_Mexico","Active,_not_recruiting","No_Results_Available","Posaconazole_Versus_Micafungin_for_Prophylaxis_Against_Invasive_Fungal_Infections_During_Neutropenia_in_Patients_Undergoing_Chemotherapy_for_Acute_Myelogenous_Leukemia,_Acute_Lymphocytic_Leukemia_or_Myelodysplastic_Syndrome"],["ACUTE_MYELOGENOUS_LEUKEMIA","District_of_Columbia","Active,_not_recruiting","No_Results_Available","Pilot_Study_of_Lupron_to_Improve_Immune_Function_After_Allogeneic_Bone_Marrow_Transplantation"],["ACUTE_MYELOGENOUS_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Intra-Osseous_Co-Transplant_of_UCB_and_hMSC"],["ACUTE_MYELOGENOUS_LEUKEMIA","Maryland","Completed","No_Results_Available","Methods_to_Enhance_the_Safety_and_Effectiveness_of_Stem_Cell_Transplants"],["ACUTE_MYELOGENOUS_LEUKEMIA","California","Completed","No_Results_Available","Haploidentical_Transplantation_in_Patients_With_Acute_Leukemia_and_Myelodysplasia"],["ACUTE_MYELOGENOUS_LEUKEMIA","Pennsylvania","Completed","No_Results_Available","AZD2171_to_Treat_Children_and_Adolescents_With_Solid_Tumors_or_Acute_Myelogenous_Leukemia"],["ACUTE_MYELOGENOUS_LEUKEMIA_(AML)","Maryland","Active,_not_recruiting","No_Results_Available","Ultra-Low_Dose_IL-2_Therapy_as_GVHD_Prophylaxis_in_Haploidentical_Allogeneic_Stem_Cell_Transplantation"],["ACUTE_MYELOGENOUS_LEUKEMIA_(AML)","New_York","Recruiting","No_Results_Available","CD34+_(Malignant)_Stem_Cell_Selection_for_Patients_Receiving_Allogenic_Stem_Cell_Transplant"],["ACUTE_MYELOGENOUS_LEUKEMIA_(AML)","New_Mexico","Recruiting","No_Results_Available","CD34+_(Malignant)_Stem_Cell_Selection_for_Patients_Receiving_Allogenic_Stem_Cell_Transplant"],["ACUTE_MYELOID_LEUKEMIA","Wisconsin","549","Not_yet_recruiting","Lintuzumab-Ac225_in_Combination_With_CLAG-M_Chemotherapy_in_Patients_With_Relapsed-Refractory_Acute_Myeloid_Leukemia"],["ACUTE_MYELOID_LEUKEMIA","North_Carolina","442","Recruiting","AML_Electronic_Decision_Aid"],["ACUTE_MYELOID_LEUKEMIA_IN_REMISSION","California","757","Not_yet_recruiting","Multi-peptide_CMV-Modified_Vaccinia_Ankara_Vaccine_in_Reducing_CMV_Related_Complications_in_Patients_With_Blood_Cancer_Undergoing_Donor_Stem_Cell_Transplant"],["ACUTE_PAIN","California","Completed","No_Results_Available","Minocycline_Hydrochloride_in_Reducing_Chemotherapy-Induced_Peripheral_Neuropathy_and_Acute_Pain_in_Patients_With_Breast_Cancer_Undergoing_Treatment_With_Paclitaxel"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","California","Completed","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_in_Treating_Young_Patients_With_Relapsed_or_Refractory_Solid_Tumors_or_Leukemia"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","North_Carolina","Active,_not_recruiting","No_Results_Available","Bioelectrical_Impedance_Measurement_for_Predicting_Treatment_Outcome_in_Patients_With_Newly_Diagnosed_Acute_Leukemia"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Texas","Terminated","No_Results_Available","Sunitinib_in_Treating_Patients_With_Idiopathic_Myelofibrosis"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Alabama","Terminated","No_Results_Available","Obatoclax_Mesylate,_Vincristine_Sulfate,_Doxorubicin_Hydrochloride,_and_Dexrazoxane_Hydrochloride_in_Treating_Young_Patients_With_Relapsed_or_Refractory_Solid_Tumors,_Lymphoma,_or_Leukemia"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Illinois","Completed","No_Results_Available","Alemtuzumab_and_Combination_Chemotherapy_in_Treating_Patients_With_Untreated_Acute_Lymphoblastic_Leukemia"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Washington","Recruiting","No_Results_Available","Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Washington","Active,_not_recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_in_Preventing_GVHD_in_Children"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Pennsylvania","Recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_From_HLA-Matched_Related_and_Unrelated_Donors_in_Preventing_GVHD"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","California","Completed","No_Results_Available","GTI-2040_in_Treating_Patients_With_Relapsed,_Refractory,_or_High-Risk_Acute_Leukemia,_High-Grade_Myelodysplastic_Syndromes,_or_Refractory_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ACUTE_UNDIFFERENTIATED_LEUKEMIA","Ohio","Completed","No_Results_Available","SB-715992_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Advanced_Myelodysplastic_Syndromes"],["ADAPTIVE_IMMUNITY","Maryland","Completed","No_Results_Available","Immune_Responses_to_Two_Experimental_HIV_Vaccines_in_Healthy_Adults"],["ADENOCARCINOMA","Maryland","Active,_not_recruiting","No_Results_Available","PANVAC-V_and_PANVAC-F_Vaccines_Plus_Sargramostim_to_Treat_Advanced_Cancer"],["ADENOCARCINOMAS","Maryland","Recruiting","No_Results_Available","Ad-HER2-Neu_Dendritic_Cell_Cancer_Vaccine_Testing"],["ADENOCARCINOMA_OF_THE_COLON","Texas","894","Not_yet_recruiting","M7824_in_Consensus_Molecular_Subtype_4,_Treatment-Refractory_Metastatic_Colorectal_Cancer"],["ADENOCARCINOMA_OF_THE_EXTRAHEPATIC_BILE_DUCT","Pennsylvania","Terminated","No_Results_Available","Bortezomib_in_Treating_Patients_With_Unresectable_Locally_Advanced_or_Metastatic_Adenocarcinoma_of_the_Bile_Duct_or_Gallbladder"],["ADENOCARCINOMA_OF_THE_GALLBLADDER","Pennsylvania","Completed","No_Results_Available","Vaccine_Therapy_With_or_Without_Sargramostim_in_Treating_Patients_With_Advanced_or_Metastatic_Cancer"],["ADENOCARCINOMA_OF_THE_GALLBLADDER","Pennsylvania","Terminated","No_Results_Available","Bortezomib_in_Treating_Patients_With_Unresectable_Locally_Advanced_or_Metastatic_Adenocarcinoma_of_the_Bile_Duct_or_Gallbladder"],["ADENOCARCINOMA_OF_THE_GALLBLADDER","Illinois","Active,_not_recruiting","No_Results_Available","Genotype-guided_Dosing_of_mFOLFIRINOX_Chemotherapy_in_Patients_With_Previously_Untreated_Advanced_Gastrointestinal_Malignancies"],["ADENOCARCINOMA_OF_THE_GASTROESOPHAGEAL_JUNCTION","New_Jersey","Terminated","No_Results_Available","Akt_Inhibitor_MK2206,_Lapatinib_Ditosylate,_and_Trastuzumab_in_Treating_Patients_With_Locally_Advanced_or_Metastatic_HER2-Positive_Breast_,_Gastric,_or_Gastroesophageal_Cancer_That_Cannot_Be_Removed_By_Surgery"],["ADENOCARCINOMA_OF_THE_GASTROESOPHAGEAL_JUNCTION","New_York","Terminated","No_Results_Available","Akt_Inhibitor_MK2206,_Lapatinib_Ditosylate,_and_Trastuzumab_in_Treating_Patients_With_Locally_Advanced_or_Metastatic_HER2-Positive_Breast_,_Gastric,_or_Gastroesophageal_Cancer_That_Cannot_Be_Removed_By_Surgery"],["ADENOCARCINOMA_OF_THE_GASTROESOPHAGEAL_JUNCTION","New_Mexico","Terminated","No_Results_Available","Akt_Inhibitor_MK2206,_Lapatinib_Ditosylate,_and_Trastuzumab_in_Treating_Patients_With_Locally_Advanced_or_Metastatic_HER2-Positive_Breast_,_Gastric,_or_Gastroesophageal_Cancer_That_Cannot_Be_Removed_By_Surgery"],["ADENOCARCINOMA_OF_THE_PANCREAS","Pennsylvania","Completed","No_Results_Available","Vaccine_Therapy_With_or_Without_Sargramostim_in_Treating_Patients_With_Advanced_or_Metastatic_Cancer"],["ADENOCARCINOMA_OF_THE_PANCREAS","Wisconsin","Terminated","No_Results_Available","Veliparib,_Oxaliplatin,_and_Capecitabine_in_Treating_Patients_With_Advanced_Solid_Tumors"],["ADENOCARCINOMA_OF_THE_PANCREAS","Nebraska","Active,_not_recruiting","No_Results_Available","Stereotactic_Radiation_Therapy,_Nelfinavir_Mesylate,_Gemcitabine_Hydrochloride,_Leucovorin_Calcium,_and_Fluorouracil_in_Treating_Patients_With_Locally_Advanced_Pancreatic_Cancer"],["ADENOCARCINOMA_OF_THE_RECTUM","Pennsylvania","Completed","No_Results_Available","Vaccine_Therapy_With_or_Without_Sargramostim_in_Treating_Patients_With_Advanced_or_Metastatic_Cancer"],["ADENOCARCINOMA_OF_THE_RECTUM","Texas","894","Not_yet_recruiting","M7824_in_Consensus_Molecular_Subtype_4,_Treatment-Refractory_Metastatic_Colorectal_Cancer"],["ADENOCARCINOMA_OF_THE_STOMACH","Wisconsin","Terminated","No_Results_Available","Veliparib,_Oxaliplatin,_and_Capecitabine_in_Treating_Patients_With_Advanced_Solid_Tumors"],["ADENOCARCINOMA_OF_UNKNOWN_PRIMARY","Illinois","Active,_not_recruiting","No_Results_Available","Genotype-guided_Dosing_of_mFOLFIRINOX_Chemotherapy_in_Patients_With_Previously_Untreated_Advanced_Gastrointestinal_Malignancies"],["ADENOID_CYSTIC_CARCINOMA","Massachusetts","Active,_not_recruiting","No_Results_Available","Intensity-Modulated_or_Proton_Radiation_Therapy_for_Sinonasal_Malignancy"],["ADENOMA,_LIVER_CELL","Maryland","Completed","No_Results_Available","Sorafenib_and_TRC105_in_Hepatocellular_Cancer"],["ADHERENCE","Massachusetts","Completed","No_Results_Available","Skills_Based_Counseling_for_Adherence_and_Depression_in_HIV+_Methadone_Patients_-_1"],["ADHERENCE","Michigan","Unknown_status","No_Results_Available","The_Aim_of_This_Study_is_to_Determine_the_Effectiveness_of_a_Motivational_Enhancement_Intervention_in_Reducing_Risk_Behaviors_(Drug_and_Alcohol_Use,_Sexual_Risk_Behavior,_Poor_Adherence_to_Medications)_Among_HIV+_Youth._-_1"],["ADHERENCE,_MEDICATION","New_York","Recruiting","No_Results_Available","Prevention_and_Risk:_Treatment_With_a_New_Emphasis_on_Relationships"],["ADHERENCE,_MEDICATION","California","Not_yet_recruiting","No_Results_Available","DOT_Diary_Optimization_Pilot"],["ADHERENCE,_PATIENT","Maryland","462","Not_yet_recruiting","A_Comparative_Effectiveness_Demonstration_Project_for_Linkage_and_Retention_in_PrEP_Care_for_Men_Who_Have_Sex_With_Men"],["ADHERENCE,_PATIENT","New_York","Active,_not_recruiting","No_Results_Available","Group_Clinical_Visit_Adherence_Intervention_for_HIV+_Women_of_Color"],["ADIPOSITY","Pennsylvania","Completed","No_Results_Available","Adiposity_and_Airway_Inflammation_in_HIV-Associated_Airway_Disease"],["ADOLESCENT","Maryland","Completed","No_Results_Available","A_Phase_I_Study_of_Quadrivalent_Human_Papilloma_Virus_(HPV)_(Types_6,_11,_16,_18)_Recombinant_Vaccine_in_HIV-Infected_and_HIV-Negative_Pre-Adolescents,_Adolescents,_and_Young_Adults"],["ADOLESCENT_BEHAVIOR","Maryland","Active,_not_recruiting","No_Results_Available","Health_Improvement_for_Maryland_Youth"],["ADOLESCENT_BEHAVIOR","Michigan","889","Not_yet_recruiting","Using_an_mHealth_App_to_Transition_Care_of_Type-1_Diabetes_From_Parents_to_Teens"],["ADOLESCENT_BEHAVIOR","New_York","Completed","No_Results_Available","Peer_Mentors_for_Adolescents_in_HIV_Affected_Families"],["ADOLESCENT_BEHAVIOR","New_York","Completed","No_Results_Available","HIV_Prevention_With_Adolescents:_Neurocognitive_Deficits_and_Treatment_Response"],["ADOLESCENT_DEVELOPMENT","Maryland","Active,_not_recruiting","No_Results_Available","Health_Improvement_for_Maryland_Youth"],["ADRENAL_CANCER","Maryland","Terminated","No_Results_Available","A_Pilot_Study_of_F-18_Paclitaxel_(FPAC)_PET_for_Evaluating_Drug_Delivery_of_Solid_Tumors_in_Breast,_Lung,_Renal,_and_Adrenal_Cancers"],["ADRENOCORTICAL_CARCINOMA","Minnesota","Completed","No_Results_Available","Combination_Chemotherapy_With_Suramin_Plus_Doxorubicin_in_Treating_Patients_With_Advanced_Solid_Tumors"],["ADRENOCORTICAL_CARCINOMA","Maryland","Completed","No_Results_Available","Tumor_Necrosis_Factor_in_Patients_Undergoing_Surgery_for_Primary_Cancer_or_Metastatic_Cancer"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Texas","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Tipifarnib_in_Treating_Patients_With_Newly_Diagnosed_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Texas","Terminated","No_Results_Available","Cilengitide_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Eltrombopag_Olamine_in_Improving_Platelet_Recovery_in_Older_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Chemotherapy"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_and_Bortezomib_in_Treating_Patients_With_Acute_Leukemia_or_Chronic_Myelogenous_Leukemia_in_Blast_Phase"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Maine","Active,_not_recruiting","No_Results_Available","Decitabine,_Cytarabine,_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","Texas","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Refractory_or_Relapsed_Acute_Leukemia,_Myelodysplastic_Syndromes,_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_BASOPHILIC_LEUKEMIA","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_and_Bortezomib_in_Treating_Patients_With_Acute_Leukemia_or_Chronic_Myelogenous_Leukemia_in_Blast_Phase"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Texas","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Refractory_or_Relapsed_Acute_Leukemia,_Myelodysplastic_Syndromes,_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Ohio","Recruiting","No_Results_Available","Eltrombopag_Olamine_in_Improving_Platelet_Recovery_in_Older_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Chemotherapy"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Texas","Terminated","No_Results_Available","Cilengitide_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Texas","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Tipifarnib_in_Treating_Patients_With_Newly_Diagnosed_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_EOSINOPHILIC_LEUKEMIA","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_ERYTHROID_LEUKEMIA_(M6)","California","Recruiting","No_Results_Available","CPX-351_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndrome"],["ADULT_ACUTE_ERYTHROID_LEUKEMIA_(M6)","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_ERYTHROID_LEUKEMIA_(M6)","Minnesota","Completed","No_Results_Available","Vorinostat_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_ERYTHROID_LEUKEMIA_(M6)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_ERYTHROID_LEUKEMIA_(M6)","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA","North_Carolina","Completed","No_Results_Available","Prolonged_or_Standard_Infusion_of_Cefepime_Hydrochloride_in_Treating_Patients_With_Febrile_Neutropenia"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA","Colorado","Recruiting","No_Results_Available","Sirolimus,_Cyclosporine,_and_Mycophenolate_Mofetil_in_Preventing_Graft-versus-Host_Disease_in_Treating_Patients_With_Blood_Cancer_Undergoing_Donor_Peripheral_Blood_Stem_Cell_Transplant"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_COMPLETE_REMISSION","New_York","Recruiting","No_Results_Available","Chemotherapy,_Total_Body_Irradiation,_and_Post-Transplant_Cyclophosphamide_in_Reducing_Rates_of_Graft_Versus_Host_Disease_in_Patients_With_Hematologic_Malignancies_Undergoing_Donor_Stem_Cell_Transplant"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_COMPLETE_REMISSION","Washington","Recruiting","No_Results_Available","Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_COMPLETE_REMISSION","Colorado","Recruiting","No_Results_Available","Umbilical_Cord_Blood_Transplant,_Cyclophosphamide,_Fludarabine_Phosphate,_and_Total-Body_Irradiation_in_Treating_Patients_With_Hematologic_Disease"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_COMPLETE_REMISSION","California","Recruiting","No_Results_Available","Total_Marrow_and_Lymphoid_Irradiation_and_Chemotherapy_Before_Donor_Transplant_in_Treating_Patients_With_Myelodysplastic_Syndrome_or_Acute_Leukemia"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","Active,_not_recruiting","No_Results_Available","Fludarabine_Phosphate,_Low-Dose_Total_Body_Irradiation,_and_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Hematologic_Malignancies_or_Kidney_Cancer"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","Recruiting","No_Results_Available","Clofarabine_and_Melphalan_Before_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_Myelodysplasia,_Acute_Leukemia_in_Remission,_or_Chronic_Myelomonocytic_Leukemia"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Colorado","Recruiting","No_Results_Available","Treosulfan,_Fludarabine_Phosphate,_and_Total-Body_Irradiation_in_Treating_Patients_With_Hematological_Cancer_Who_Are_Undergoing_Umbilical_Cord_Blood_Transplant"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Washington","Active,_not_recruiting","No_Results_Available","Iodine_I_131_Monoclonal_Antibody_BC8,_Fludarabine_Phosphate,_Cyclophosphamide,_Total-Body_Irradiation_and_Donor_Bone_Marrow_Transplant_in_Treating_Patients_With_Advanced_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_High-Risk_Myelodysplastic_Syndrome"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Maryland","Completed","No_Results_Available","MS-275_and_GM-CSF_in_Treating_Patients_With_Myelodysplastic_Syndrome_and-or_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Acute_Lymphocytic_Leukemia"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","Completed","No_Results_Available","Nilotinib_and_Imatinib_Mesylate_After_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_ALL_or_CML"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Pennsylvania","Recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_From_HLA-Matched_Related_and_Unrelated_Donors_in_Preventing_GVHD"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","California","Active,_not_recruiting","No_Results_Available","Vaccine_Therapy_in_Reducing_the_Frequency_of_Cytomegalovirus_Events_in_Patients_With_Hematologic_Malignancies_Undergoing_Donor_Stem_Cell_Transplant"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Texas","Terminated","No_Results_Available","Sunitinib_in_Treating_Patients_With_Idiopathic_Myelofibrosis"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Washington","Active,_not_recruiting","No_Results_Available","Selective_Depletion_of_CD45RA+_T_Cells_From_Allogeneic_Peripheral_Blood_Stem_Cell_Grafts_in_Preventing_GVHD_in_Children"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Colorado","Active,_not_recruiting","No_Results_Available","Fludarabine_Phosphate_and_Total-Body_Irradiation_Followed_by_Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_Acute_Lymphoblastic_Leukemia_or_Chronic_Myelogenous_Leukemia_That_Has_Responded_to_Treatment_With_Imatinib_Mesylate,_Dasatinib,_or_Nilotinib"],["ADULT_ACUTE_LYMPHOBLASTIC_LEUKEMIA_IN_REMISSION","Colorado","Completed","No_Results_Available","Treosulfan,_Fludarabine_Phosphate,_and_Total-Body_Irradiation_Before_Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia,_Myelodysplastic_Syndrome,_Acute_Lymphoblastic_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Texas","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Refractory_or_Relapsed_Acute_Leukemia,_Myelodysplastic_Syndromes,_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Delaware","Completed","No_Results_Available","Busulfan,_Fludarabine_Phosphate,_and_Anti-Thymocyte_Globulin_Followed_By_Donor_Stem_Cell_Transplant_and_Azacitidine_in_Treating_Patients_With_High-Risk_Myelodysplastic_Syndrome_and_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Maryland","Active,_not_recruiting","No_Results_Available","Veliparib_and_Topotecan_With_or_Without_Carboplatin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_High-Risk_Myelodysplasia,_or_Aggressive_Myeloproliferative_Disorders"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_and_Bortezomib_in_Treating_Patients_With_Acute_Leukemia_or_Chronic_Myelogenous_Leukemia_in_Blast_Phase"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","New_York","Unknown_status","No_Results_Available","Lenalidomide_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia_Who_Have_Undergone_Stem_Cell_Transplant"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA","Arizona","Completed","No_Results_Available","Cytarabine_With_or_Without_SCH_900776_in_Treating_Adult_Patients_With_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Washington","Active,_not_recruiting","No_Results_Available","Treatment_for_Relapsed-Refractory_AML_Based_on_a_High_Throughput_Drug_Sensitivity_Assay"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Texas","Terminated","No_Results_Available","Cilengitide_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Terminated","No_Results_Available","Ixazomib_(MLN9708)_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","New_York","Terminated","No_Results_Available","AML_Therapy_With_Irradiated_Allogeneic_Cells"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Washington","Completed","No_Results_Available","Clofarabine,_Cytarabine,_and_Filgrastim_Followed_by_Infusion_of_Non-HLA_Matched_Ex_Vivo_Expanded_Cord_Blood_Progenitors_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Completed","No_Results_Available","Vorinostat,_Azacitidine,_and_Gemtuzumab_Ozogamicin_for_Older_Patients_With_Relapsed_or_Refractory_AML"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Illinois","Active,_not_recruiting","No_Results_Available","Azacitidine,_Cytarabine,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Ohio","Recruiting","No_Results_Available","Eltrombopag_Olamine_in_Improving_Platelet_Recovery_in_Older_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Chemotherapy"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","7-Hydroxystaurosporine_and_Perifosine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_Chronic_Myelogenous_Leukemia_or_High_Risk_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Washington","Completed","No_Results_Available","Early_Discharge_and_Outpatients_Care_in_Patients_With_Myelodysplastic_Syndrome_or_Acute_Myeloid_Leukemia_Previously_Treated_With_Intensive_Chemotherapy"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Ohio","Completed","No_Results_Available","SB-715992_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Advanced_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Washington","Terminated","No_Results_Available","Decitabine_Followed_by_Idarubicin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_AML_and_MDS"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Texas","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Tipifarnib_in_Treating_Patients_With_Newly_Diagnosed_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Washington","Terminated","No_Results_Available","Cyclosporine,_Pravastatin_Sodium,_Etoposide,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","New_York","Completed","No_Results_Available","Trebananib_With_or_Without_Low-Dose_Cytarabine_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","MS-275_and_GM-CSF_in_Treating_Patients_With_Myelodysplastic_Syndrome_and-or_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Acute_Lymphocytic_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Recruiting","No_Results_Available","Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High_Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Georgia","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed,_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","New_York","Terminated","No_Results_Available","Cholecalciferol_in_Treating_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Intensive_Induction_Chemotherapy"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_Valspodar_in_Treating_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","Flavopiridol,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Recruiting","No_Results_Available","CPX-351_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndrome"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Washington","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Pravastatin_Sodium_in_Treating_Patients_With_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Recruiting","No_Results_Available","Lenalidomide_and_Combination_Chemotherapy_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Texas","Completed","No_Results_Available","S0432_Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Ohio","Completed","No_Results_Available","Lithium_Carbonate_and_Tretinoin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Alabama","Completed","No_Results_Available","Comparing_Three_Different_Combination_Chemotherapy_Regimens_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Minnesota","Completed","No_Results_Available","Vorinostat_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Texas","Completed","No_Results_Available","AKT_Inhibitor_MK-2206_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Oregon","Active,_not_recruiting","No_Results_Available","Reduced_Intensity_Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_De_Novo_or_Secondary_Acute_Myeloid_Leukemia_in_Remission"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","California","Terminated","No_Results_Available","Vorinostat_and_Gemtuzumab_Ozogamicin_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","District_of_Columbia","Completed","No_Results_Available","Bortezomib,_Daunorubicin,_and_Cytarabine_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","New_York","Completed","No_Results_Available","Choline_Magnesium_Trisalicylate_and_Combination_Chemotherapy_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","New_York","Terminated","No_Results_Available","Omacetaxine_Mepesuccinate,_Cytarabine,_and_Decitabine_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MEGAKARYOBLASTIC_LEUKEMIA_(M7)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","New_York","Unknown_status","No_Results_Available","Lenalidomide_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia_Who_Have_Undergone_Stem_Cell_Transplant"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Delaware","Completed","No_Results_Available","Busulfan,_Fludarabine_Phosphate,_and_Anti-Thymocyte_Globulin_Followed_By_Donor_Stem_Cell_Transplant_and_Azacitidine_in_Treating_Patients_With_High-Risk_Myelodysplastic_Syndrome_and_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Texas","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Refractory_or_Relapsed_Acute_Leukemia,_Myelodysplastic_Syndromes,_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Maine","Active,_not_recruiting","No_Results_Available","Decitabine,_Cytarabine,_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Maryland","Active,_not_recruiting","No_Results_Available","Veliparib_and_Topotecan_With_or_Without_Carboplatin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_High-Risk_Myelodysplasia,_or_Aggressive_Myeloproliferative_Disorders"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Arizona","Completed","No_Results_Available","Cytarabine_With_or_Without_SCH_900776_in_Treating_Adult_Patients_With_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_and_Bortezomib_in_Treating_Patients_With_Acute_Leukemia_or_Chronic_Myelogenous_Leukemia_in_Blast_Phase"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Ohio","Completed","No_Results_Available","Lithium_Carbonate_and_Tretinoin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Texas","Completed","No_Results_Available","S0432_Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Texas","Completed","No_Results_Available","AKT_Inhibitor_MK-2206_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Oregon","Active,_not_recruiting","No_Results_Available","Reduced_Intensity_Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_De_Novo_or_Secondary_Acute_Myeloid_Leukemia_in_Remission"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Terminated","No_Results_Available","Vorinostat_and_Gemtuzumab_Ozogamicin_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Washington","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Pravastatin_Sodium_in_Treating_Patients_With_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","District_of_Columbia","Completed","No_Results_Available","Bortezomib,_Daunorubicin,_and_Cytarabine_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Alabama","Completed","No_Results_Available","Comparing_Three_Different_Combination_Chemotherapy_Regimens_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","Flavopiridol,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_Valspodar_in_Treating_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","New_York","Completed","No_Results_Available","Trebananib_With_or_Without_Low-Dose_Cytarabine_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Washington","Terminated","No_Results_Available","Cyclosporine,_Pravastatin_Sodium,_Etoposide,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Texas","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Tipifarnib_in_Treating_Patients_With_Newly_Diagnosed_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Terminated","No_Results_Available","Ixazomib_(MLN9708)_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Washington","Active,_not_recruiting","No_Results_Available","Treatment_for_Relapsed-Refractory_AML_Based_on_a_High_Throughput_Drug_Sensitivity_Assay"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Arizona","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_Hydrochloride_or_Cytarabine_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Georgia","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed,_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Texas","Terminated","No_Results_Available","Cilengitide_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","New_York","Terminated","No_Results_Available","AML_Therapy_With_Irradiated_Allogeneic_Cells"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","MS-275_and_GM-CSF_in_Treating_Patients_With_Myelodysplastic_Syndrome_and-or_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Acute_Lymphocytic_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","New_York","Terminated","No_Results_Available","Omacetaxine_Mepesuccinate,_Cytarabine,_and_Decitabine_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Terminated","No_Results_Available","MEK_Inhibitor_MEK162,_Idarubicin,_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Washington","Completed","No_Results_Available","Clofarabine,_Cytarabine,_and_Filgrastim_Followed_by_Infusion_of_Non-HLA_Matched_Ex_Vivo_Expanded_Cord_Blood_Progenitors_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","New_York","Completed","No_Results_Available","Choline_Magnesium_Trisalicylate_and_Combination_Chemotherapy_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Minnesota","Completed","No_Results_Available","Vorinostat_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Recruiting","No_Results_Available","Lenalidomide_and_Combination_Chemotherapy_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Recruiting","No_Results_Available","Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High_Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","New_York","Terminated","No_Results_Available","Cholecalciferol_in_Treating_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Intensive_Induction_Chemotherapy"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Washington","Terminated","No_Results_Available","Decitabine_Followed_by_Idarubicin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_AML_and_MDS"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Ohio","Completed","No_Results_Available","SB-715992_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Advanced_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Washington","Completed","No_Results_Available","Early_Discharge_and_Outpatients_Care_in_Patients_With_Myelodysplastic_Syndrome_or_Acute_Myeloid_Leukemia_Previously_Treated_With_Intensive_Chemotherapy"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","7-Hydroxystaurosporine_and_Perifosine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_Chronic_Myelogenous_Leukemia_or_High_Risk_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","California","Completed","No_Results_Available","Vorinostat,_Azacitidine,_and_Gemtuzumab_Ozogamicin_for_Older_Patients_With_Relapsed_or_Refractory_AML"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Ohio","Recruiting","No_Results_Available","Eltrombopag_Olamine_in_Improving_Platelet_Recovery_in_Older_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Chemotherapy"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_(M5A)","Illinois","Active,_not_recruiting","No_Results_Available","Azacitidine,_Cytarabine,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_AND_ACUTE_MONOCYTIC_LEUKEMIA_(M5)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_AND_ACUTE_MONOCYTIC_LEUKEMIA_(M5)","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_AND_ACUTE_MONOCYTIC_LEUKEMIA_(M5)","California","Recruiting","No_Results_Available","CPX-351_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndrome"],["ADULT_ACUTE_MONOBLASTIC_LEUKEMIA_AND_ACUTE_MONOCYTIC_LEUKEMIA_(M5)","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Maine","Active,_not_recruiting","No_Results_Available","Decitabine,_Cytarabine,_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Delaware","Completed","No_Results_Available","Busulfan,_Fludarabine_Phosphate,_and_Anti-Thymocyte_Globulin_Followed_By_Donor_Stem_Cell_Transplant_and_Azacitidine_in_Treating_Patients_With_High-Risk_Myelodysplastic_Syndrome_and_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Maryland","Active,_not_recruiting","No_Results_Available","Veliparib_and_Topotecan_With_or_Without_Carboplatin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_High-Risk_Myelodysplasia,_or_Aggressive_Myeloproliferative_Disorders"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_and_Bortezomib_in_Treating_Patients_With_Acute_Leukemia_or_Chronic_Myelogenous_Leukemia_in_Blast_Phase"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Texas","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Refractory_or_Relapsed_Acute_Leukemia,_Myelodysplastic_Syndromes,_or_Blastic_Phase_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","New_York","Unknown_status","No_Results_Available","Lenalidomide_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia_Who_Have_Undergone_Stem_Cell_Transplant"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Arizona","Completed","No_Results_Available","Cytarabine_With_or_Without_SCH_900776_in_Treating_Adult_Patients_With_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA","Florida","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Terminated","No_Results_Available","MEK_Inhibitor_MEK162,_Idarubicin,_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Washington","Active,_not_recruiting","No_Results_Available","Treatment_for_Relapsed-Refractory_AML_Based_on_a_High_Throughput_Drug_Sensitivity_Assay"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Washington","Completed","No_Results_Available","Early_Discharge_and_Outpatients_Care_in_Patients_With_Myelodysplastic_Syndrome_or_Acute_Myeloid_Leukemia_Previously_Treated_With_Intensive_Chemotherapy"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","7-Hydroxystaurosporine_and_Perifosine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_Chronic_Myelogenous_Leukemia_or_High_Risk_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Ohio","Completed","No_Results_Available","SB-715992_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Advanced_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Washington","Terminated","No_Results_Available","Decitabine_Followed_by_Idarubicin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_AML_and_MDS"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Recruiting","No_Results_Available","Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High_Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","New_York","Terminated","No_Results_Available","Cholecalciferol_in_Treating_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Intensive_Induction_Chemotherapy"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","New_York","Terminated","No_Results_Available","AML_Therapy_With_Irradiated_Allogeneic_Cells"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Completed","No_Results_Available","Vorinostat,_Azacitidine,_and_Gemtuzumab_Ozogamicin_for_Older_Patients_With_Relapsed_or_Refractory_AML"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Illinois","Active,_not_recruiting","No_Results_Available","Azacitidine,_Cytarabine,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Ohio","Recruiting","No_Results_Available","Eltrombopag_Olamine_in_Improving_Platelet_Recovery_in_Older_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Chemotherapy"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","MS-275_and_GM-CSF_in_Treating_Patients_With_Myelodysplastic_Syndrome_and-or_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Acute_Lymphocytic_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Georgia","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed,_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Arizona","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_Hydrochloride_or_Cytarabine_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_Valspodar_in_Treating_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Washington","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Pravastatin_Sodium_in_Treating_Patients_With_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Texas","Completed","No_Results_Available","S0432_Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Ohio","Completed","No_Results_Available","Lithium_Carbonate_and_Tretinoin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Texas","Completed","No_Results_Available","AKT_Inhibitor_MK-2206_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Oregon","Active,_not_recruiting","No_Results_Available","Reduced_Intensity_Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_De_Novo_or_Secondary_Acute_Myeloid_Leukemia_in_Remission"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Terminated","No_Results_Available","Vorinostat_and_Gemtuzumab_Ozogamicin_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","District_of_Columbia","Completed","No_Results_Available","Bortezomib,_Daunorubicin,_and_Cytarabine_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Alabama","Completed","No_Results_Available","Comparing_Three_Different_Combination_Chemotherapy_Regimens_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","Flavopiridol,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Washington","Completed","No_Results_Available","Clofarabine,_Cytarabine,_and_Filgrastim_Followed_by_Infusion_of_Non-HLA_Matched_Ex_Vivo_Expanded_Cord_Blood_Progenitors_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","New_York","Completed","No_Results_Available","Trebananib_With_or_Without_Low-Dose_Cytarabine_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Washington","Terminated","No_Results_Available","Cyclosporine,_Pravastatin_Sodium,_Etoposide,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Texas","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Tipifarnib_in_Treating_Patients_With_Newly_Diagnosed_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Terminated","No_Results_Available","Ixazomib_(MLN9708)_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","California","Recruiting","No_Results_Available","Lenalidomide_and_Combination_Chemotherapy_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Minnesota","Completed","No_Results_Available","Vorinostat_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Texas","Terminated","No_Results_Available","Cilengitide_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","New_York","Completed","No_Results_Available","Choline_Magnesium_Trisalicylate_and_Combination_Chemotherapy_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MONOCYTIC_LEUKEMIA_(M5B)","New_York","Terminated","No_Results_Available","Omacetaxine_Mepesuccinate,_Cytarabine,_and_Decitabine_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Texas","Terminated","No_Results_Available","Cilengitide_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Terminated","No_Results_Available","Ixazomib_(MLN9708)_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","New_York","Terminated","No_Results_Available","Omacetaxine_Mepesuccinate,_Cytarabine,_and_Decitabine_in_Treating_Older_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","New_York","Completed","No_Results_Available","Choline_Magnesium_Trisalicylate_and_Combination_Chemotherapy_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","Tipifarnib_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Minnesota","Completed","No_Results_Available","Vorinostat_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Terminated","No_Results_Available","Bortezomib_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia_in_Remission"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Recruiting","No_Results_Available","Lenalidomide_and_Combination_Chemotherapy_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Recruiting","No_Results_Available","CPX-351_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndrome"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Oregon","Active,_not_recruiting","No_Results_Available","Reduced_Intensity_Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_De_Novo_or_Secondary_Acute_Myeloid_Leukemia_in_Remission"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","New_York","Terminated","No_Results_Available","Cholecalciferol_in_Treating_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Intensive_Induction_Chemotherapy"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Texas","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Tipifarnib_in_Treating_Patients_With_Newly_Diagnosed_Myelodysplastic_Syndromes_or_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Recruiting","No_Results_Available","Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High_Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Terminated","No_Results_Available","Cyclosporine,_Pravastatin_Sodium,_Etoposide,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","New_York","Completed","No_Results_Available","Trebananib_With_or_Without_Low-Dose_Cytarabine_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Ohio","Completed","No_Results_Available","SB-715992_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Advanced_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Terminated","No_Results_Available","Decitabine_Followed_by_Idarubicin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_AML_and_MDS"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","Flavopiridol,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Completed","No_Results_Available","Early_Discharge_and_Outpatients_Care_in_Patients_With_Myelodysplastic_Syndrome_or_Acute_Myeloid_Leukemia_Previously_Treated_With_Intensive_Chemotherapy"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Texas","Completed","No_Results_Available","AKT_Inhibitor_MK-2206_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","7-Hydroxystaurosporine_and_Perifosine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia,_Chronic_Myelogenous_Leukemia_or_High_Risk_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Terminated","No_Results_Available","Vorinostat_and_Gemtuzumab_Ozogamicin_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Completed","No_Results_Available","Tipifarnib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Ohio","Completed","No_Results_Available","Lithium_Carbonate_and_Tretinoin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Texas","Completed","No_Results_Available","S0432_Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","MS-275_and_GM-CSF_in_Treating_Patients_With_Myelodysplastic_Syndrome_and-or_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Acute_Lymphocytic_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Terminated","No_Results_Available","MEK_Inhibitor_MEK162,_Idarubicin,_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Pravastatin_Sodium_in_Treating_Patients_With_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Active,_not_recruiting","No_Results_Available","Treatment_for_Relapsed-Refractory_AML_Based_on_a_High_Throughput_Drug_Sensitivity_Assay"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Alabama","Completed","No_Results_Available","Comparing_Three_Different_Combination_Chemotherapy_Regimens_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","District_of_Columbia","Completed","No_Results_Available","Bortezomib,_Daunorubicin,_and_Cytarabine_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","New_York","Terminated","No_Results_Available","AML_Therapy_With_Irradiated_Allogeneic_Cells"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Washington","Completed","No_Results_Available","Clofarabine,_Cytarabine,_and_Filgrastim_Followed_by_Infusion_of_Non-HLA_Matched_Ex_Vivo_Expanded_Cord_Blood_Progenitors_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_PSC_833,_Peripheral_Stem_Cell_Transplantation,_and-or_Interleukin-2_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Georgia","Completed","No_Results_Available","Tipifarnib_and_Etoposide_in_Treating_Older_Patients_With_Newly_Diagnosed,_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_Valspodar_in_Treating_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","California","Completed","No_Results_Available","Vorinostat,_Azacitidine,_and_Gemtuzumab_Ozogamicin_for_Older_Patients_With_Relapsed_or_Refractory_AML"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Illinois","Active,_not_recruiting","No_Results_Available","Azacitidine,_Cytarabine,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_High-Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Ohio","Recruiting","No_Results_Available","Eltrombopag_Olamine_in_Improving_Platelet_Recovery_in_Older_Patients_With_Acute_Myeloid_Leukemia_Undergoing_Chemotherapy"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Arizona","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_Hydrochloride_or_Cytarabine_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITHOUT_MATURATION_(M1)","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Ohio","Terminated","No_Results_Available","Flavopiridol_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Oregon","Active,_not_recruiting","No_Results_Available","Reduced_Intensity_Donor_Peripheral_Blood_Stem_Cell_Transplant_in_Treating_Patients_With_De_Novo_or_Secondary_Acute_Myeloid_Leukemia_in_Remission"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Minnesota","Completed","No_Results_Available","Vorinostat_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Texas","Terminated","No_Results_Available","Idarubicin_and_Cytarabine_With_or_Without_Bevacizumab_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Maryland","Completed","No_Results_Available","MS-275_and_GM-CSF_in_Treating_Patients_With_Myelodysplastic_Syndrome_and-or_Relapsed_or_Refractory_Acute_Myeloid_Leukemia_or_Acute_Lymphocytic_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Illinois","Completed","No_Results_Available","Combination_Chemotherapy_With_or_Without_Valspodar_in_Treating_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Texas","Completed","No_Results_Available","XK469R_in_Treating_Patients_With_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Maryland","Completed","No_Results_Available","Vorinostat,_Cytarabine,_and_Etoposide_in_Treating_Patients_With_Relapsed_and-or_Refractory_Acute_Leukemia_or_Myelodysplastic_Syndromes_or_Myeloproliferative_Disorders"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","New_York","Completed","No_Results_Available","Choline_Magnesium_Trisalicylate_and_Combination_Chemotherapy_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Washington","Completed","No_Results_Available","Idarubicin,_Cytarabine,_and_Pravastatin_Sodium_in_Treating_Patients_With_Acute_Myeloid_Leukemia_or_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Washington","Active,_not_recruiting","No_Results_Available","Treatment_for_Relapsed-Refractory_AML_Based_on_a_High_Throughput_Drug_Sensitivity_Assay"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","New_York","Terminated","No_Results_Available","Entinostat_and_Sorafenib_Tosylate_in_Treating_Patients_With_Advanced_or_Metastatic_Solid_Tumors_or_Refractory_or_Relapsed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Texas","Completed","No_Results_Available","S0432_Tipifarnib_in_Treating_Older_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Maryland","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","District_of_Columbia","Completed","No_Results_Available","Bortezomib,_Daunorubicin,_and_Cytarabine_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Maryland","Completed","No_Results_Available","Flavopiridol,_Cytarabine,_and_Mitoxantrone_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Maryland","Completed","No_Results_Available","Sorafenib_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_or_Chronic_Myelogenous_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Washington","Terminated","No_Results_Available","Cyclosporine,_Pravastatin_Sodium,_Etoposide,_and_Mitoxantrone_Hydrochloride_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Ohio","Completed","No_Results_Available","SB-715992_in_Treating_Patients_With_Acute_Leukemia,_Chronic_Myelogenous_Leukemia,_or_Advanced_Myelodysplastic_Syndromes"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","California","Terminated","No_Results_Available","Ixazomib_(MLN9708)_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Washington","Completed","No_Results_Available","Clofarabine,_Cytarabine,_and_Filgrastim_Followed_by_Infusion_of_Non-HLA_Matched_Ex_Vivo_Expanded_Cord_Blood_Progenitors_in_Treating_Patients_With_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","California","Recruiting","No_Results_Available","Donor_Stem_Cell_Transplant_in_Treating_Patients_With_High_Risk_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Ohio","Completed","No_Results_Available","Lithium_Carbonate_and_Tretinoin_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Ohio","Terminated","No_Results_Available","17-N-Allylamino-17-Demethoxygeldanamycin_and_Bortezomib_in_Treating_Patients_With_Relapsed_or_Refractory_Hematologic_Cancer"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","California","Terminated","No_Results_Available","Vorinostat_and_Gemtuzumab_Ozogamicin_in_Treating_Older_Patients_With_Previously_Untreated_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Arizona","Completed","No_Results_Available","Alvocidib,_Cytarabine,_and_Mitoxantrone_Hydrochloride_or_Cytarabine_and_Daunorubicin_Hydrochloride_in_Treating_Patients_With_Newly_Diagnosed_Acute_Myeloid_Leukemia"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","New_York","Terminated","No_Results_Available","AML_Therapy_With_Irradiated_Allogeneic_Cells"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Washington","Completed","No_Results_Available","Early_Discharge_and_Outpatients_Care_in_Patients_With_Myelodysplastic_Syndrome_or_Acute_Myeloid_Leukemia_Previously_Treated_With_Intensive_Chemotherapy"],["ADULT_ACUTE_MYELOBLASTIC_LEUKEMIA_WITH_MATURATION_(M2)","Minnesota","Completed","No_Results_Available","Tanespimycin_and_Cytarabine_in_Treating_Patients_With_Relapsed_or_Refractory_Acute_Myeloid_Leukemia,_Acute_Lymphoblastic_Leukemia,_Chronic_Myelogenous_Leukemia,_Chronic_Myelomonocytic_Leukemia,_or_Myelodysplastic_Syndromes"]],"headers":["Disease","Location_1","Recruitment","Study_Results","Title"],"rawHeaders":["DISEASE","LOCATION_1","RECRUITMENT","STUDY_RESULTS","TITLE"]},"headerInfo":[{"alias":"Disease","header":"Disease","type":"STRING","derived":false},{"alias":"Location_1","header":"Location_1","type":"STRING","derived":false},{"alias":"Recruitment","header":"Recruitment","type":"STRING","derived":false},{"alias":"Study_Results","header":"Study_Results","type":"STRING","derived":false},{"alias":"Title","header":"Title","type":"STRING","derived":false}],"sortInfo":[],"numRows":13663,"numCollected":500,"taskOptions":{"0":{"layout":"Cluster","alignment":{"cluster":["Disease"],"tooltip":["Location_1","Recruitment","Study_Results","Title"],"label":["Disease"]}}},"format":{"type":"TABLE"},"filterInfo":[],"taskId":"task1"},"operationType":["TASK_DATA"]}]}